Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 709-penis-procedures-with-cc-mcc
    Ask Trek AI about this page

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    DRG 709 encompasses inpatient penile procedures with a Complication or Comorbidity or Major Complication or Comorbidity, including repair, reconstruction, and management of trauma or infection, affecting clinical complexity. It matters for inpatient reimbursement because the presence of Complication or Comorbidity or Major Complication or Comorbidity changes resource use and groups cases into higher-paying Diagnosis-Related Group classifications under Medicare.

    Customize your policy alerts

    Sign up for drg 709 policy alerts

    Get alerted when payer policies referencing 709 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 709 Overview

    DRG 709 covers inpatient hospital admissions for penile procedures when a Complication or Comorbidity or Major Complication or Comorbidity is present, including surgical repair, reconstruction, and procedures for trauma or infection. This Diagnosis-Related Group groups cases with higher clinical complexity that influence resource use, length of stay, and reimbursement under Medicare payment systems. Accurate coding of associated diagnoses and procedures is essential because presence of a Complication or Comorbidity or Major Complication or Comorbidity can increase the payment relative to non-complicated cases. The category is relevant to urology, trauma, and inpatient surgical services managing penile conditions.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute perioperative management trials investigating strategies to reduce operative complications and shorten hospital length of stay after complex penile surgeries (such as reconstruction for trauma, penile prosthesis implantation with complications, or extensive debridement). These studies enroll inpatients undergoing index penis procedures with comorbidities or intraoperative complications to compare enhanced recovery protocols, anesthesia approaches, or infection-prevention bundles. Results are directly relevant to providers and payers because they target drivers of inpatient resource use, readmissions, and costly CC/MCC-level complications that determine DRG payments and quality metrics.
    • Comparative effectiveness studies evaluating surgical techniques and device selection for men with complicated erectile dysfunction, severe penile deformity, or recurrent prosthesis infection requiring inpatient care. These trials compare outcomes such as device survival, reoperation rates, functional outcomes, and complication profiles across different operative approaches or implant types in populations with prior failed procedures or significant comorbidity. Payers and clinicians benefit from such evidence to guide coverage policies, procedure selection, and risk stratification for patients who are most likely to incur CC/MCC-level care and downstream costs.
    • Post-discharge outcomes and readmission prevention research focusing on rehabilitation, wound care protocols, and long-term functional and psychosocial outcomes after major penile procedures performed during inpatient stays. These cohort studies follow patients discharged after CC/MCC-level penile operations to identify predictors of readmission, persistent infection, or device failure and to assess resource utilization and patient-reported quality of life over months to years. Findings inform care pathways, case management, and authorization of post-acute services that can reduce costly readmissions and improve value for payers managing this DRG.

    Related Codes

    707-MAJOR-MALE-PELVIC-PROCEDURES-WITH-CC-MCC

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    708-MAJOR-MALE-PELVIC-PROCEDURES-WITHOUT-CC-MCC

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    711-TESTES-PROCEDURES-WITH-CC-MCC

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    715-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    716-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITHOUT-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    717-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-EXCEPT-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.